Medicine

Xueqiang Wu , Chief Physician, Principal Investigator, Doctoral Supervisor, Master’s Supervisor. He holds a PhD in Hematology from West China University of Medical Sciences and completed his postdoctoral research in Oncology at the National Institutes of Health (NIH) in the United States. He serves as the Editorial Director and Deputy Editor-in-Chief of the *Chinese Journal of Modern Medicine*, Executive Director of the Chinese Association of Geriatric Research and Healthcare, Executive Vice President and Secretary-General of the Tumor Prevention and Treatment Branch of the Chinese Association of Geriatric Research and Healthcare, and Director of the Henan Engineering Research Center for Digital and Intelligent Diagnosis and Treatment of Hematologic and Oncologic Diseases. He was formerly the Vice President of Henan Shengde Hospital. Over his 40-year career, he has worked at prestigious institutions such as the National Institutes of Health, Beijing Daopei Hospital, Beijing Aerospace General Hospital, and Henan Provincial Chest Hospital. He has also pursued advanced studies at renowned universities and hospitals, including Tsinghua University, Peking University, Renji Hospital affiliated with Shanghai Jiao Tong University, Beijing Chest Hospital, and Beijing Foreign Studies University. Dr. Wu has led, participated in, and organized nearly 100 national, provincial, and municipal research projects, and has published over 100 papers in domestic and international professional journals. He has received more than ten provincial, ministerial, and bureau-level science and technology awards. He is the editor-in-chief of the medical monograph *New Advances in Lung Cancer Prevention and Treatment* and the lead author of the *Chinese Guidelines for the Diagnosis and Treatment of Lymphoma in the Elderly*.